Detection of a novel DNA virus (TTV) in blood donors and blood products

Lancet

Volumn 352, Issue 9123, 1998, Pages 191-195

  Simmonds, P ^a   Davidson, F ^b   Lycett, C ^a   Prescott, L E ^a   MacDonald, D M ^a   Ellender, J ^a   Yap, P L ^b   Ludlam, C A ^c   Haydon, G H ^b   Gillon, J ^b   Jarvis, L M ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9; BLOOD DERIVATIVE; DNA; IMMUNOGLOBULIN;

ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; CONTAMINATION; DNA VIRUS; HEPATITIS; HEPATITIS C VIRUS; HUMAN; LIVER FAILURE; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TORQUE TENO VIRUS; VIREMIA; VIRUS DETECTION; VIRUS INFECTION;

EID: 0032543942     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)03056-6     Document Type: Article

References (21)

1. 1 Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood-borne non-A, non-B hepatitis genome. Science 1989; 244: 359-62.
2. 2 Alter HJ. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 1997; 37: 569-72.
3. 3 Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transminase levels in posttrasfusion hepatitis of unknown aetiology. Biochem Biophys Res Commun 1997; 241: 92-97.
4. 4 Okamoto H, Nishizawa T, Kato N, et al. Molecular cloning and characterisation of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown aetiology. Hepatology Res 1998; 10: 1-16.
5. 5 Haydon GH, Jarvis LM, Simpson KJ, Hayes PC, Simmonds P. The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant presumed viral hepatitis. J Viral Hepat 1997; 4: 45-49.
6. 6 Jarvis LM, Watson HG, McOmish F, Peutherer JF, Ludlam CA, Simmonds P. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J Infect Dis 1994; 170: 1018-22.
7. 7 Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Brown AJ. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 1990; 64: 864-72.
8. 8 Kumar S, Tamura K, Nei M. MEGA: Molecular evolutionary genetics analysis, version 1.0. Pennsylvania: Pennsylvania State University, 1993.
9. 9 McOmish F, Chan S-W, Dow BC, et al. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in seriological reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993; 33: 7-13.
10. 10 Kernoff PBA, Lee CA, Karayiannis P, Thomas HC. High risk of non-A, non-B hepatitis after a first exposure of volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol 1985; 60: 469-79.
11. 11 Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludlam Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-55.
12. 12 Hanley JP, Jarvis LM, Hayes PC, Lee AJ, Simmonds P, Ludlam CA. Patterns of hepatitis G viraemia and liver disease in haemophiliacs previously exposed to non-virus inactivated coagulation factor concentrates. Thromb Haemost 1998; 79: 291-95.
13. 13 Yap PL. The viral safety of intravenous immune globulin. Clin Exp Immunol 1996; 104: 35-42.
14. 14 Garson JA, Preston FE, Makris M, et al. Detection by PCR of hepatitis C virus in factor VIII concentrates. Lancet 1990; 335: 1473.
15. 15 Simmonds P, Zhang LQ, Watson HG, et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet 1990; 336: 1469-72.
16. 16 Kedda MA, Kew MC, Cohn RJ, et al. An outbreak of hepatitis A among South African patients swith hemophilia: evidence implicating contaminated factor VIII concentrate as the source. Hepatology 1995; 22: 1363-67.
17. 17 Lawlor E, Johnson Z, Thornton L, Temperley I. Investigation of an outbreak of hepatitis A in Irish haemophilia A patients. Vox Sang 1994; 67 (suppl): 18-19.
18. 18 Mannucci PM, Gdovin S, Gringeri A, et al. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses: the Italian Collaborative Group. Ann Intern Med 1994; 120: 1-7.
19. 19 Lefrere JJ, Mariotti M, Thauvin M. B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates. Lancet 1994; 343: 211-12.
20. 20 Fagan EA, Smith PM, Davison F, Williams R. Fulminant hepatitis B in successive female sexual partners of two anti-HBe positive males. Lancet 1986; i: 538-40.
21. 21 Carman WF, Fagan EA, Hadziyannis S, et al. Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology 1991; 14: 219-22.